Actavis UK Ltd

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk
Medical Information Fax:

Patient Information Leaflet last updated on the eMC: 10/05/2011
PIL Nabumetone Tablets 500mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 17/09/2009 and displayed until 10/05/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 31/07/2007 and displayed until 17/09/2009
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 08/05/2007 and displayed until 31/07/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/06/2006 and displayed until 08/05/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 16/06/2006 and displayed until 26/06/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   nabumetone